Sale!

APOL1 Gene Focal Segmental Glomerulosclerosis Type 4 Susceptibility To Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The APOL1 Gene Focal Segmental Glomerulosclerosis Type 4 Susceptibility Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to assess an individual’s risk of developing Focal Segmental Glomerulosclerosis (FSGS) Type 4. This condition is a severe form of kidney disease that can lead to significant health complications, including kidney failure. The test specifically targets the APOL1 gene, which has been identified as a significant risk factor for FSGS among certain populations. Variations in the APOL1 gene can significantly increase an individual’s susceptibility to developing this kidney disease.

The process involves a detailed analysis of the patient’s genetic material to identify mutations in the APOL1 gene that are associated with an increased risk of FSGS Type 4. The results of this test can provide valuable information for patients and their healthcare providers, enabling them to understand their risk level and potentially take preventive measures or consider early interventions to manage the condition more effectively.

The cost of the APOL1 Gene Focal Segmental Glomerulosclerosis Type 4 Susceptibility Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated nature of the genetic testing and analysis required to accurately assess the risk associated with the APOL1 gene variations. Patients interested in undergoing this test should contact DNA Labs UAE for more information on the procedure, preparation, and any additional details related to the testing process.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

APOL1 Gene Focal segmental glomerulosclerosis type 4 susceptibility to Genetic Test

Test Name: APOL1 Gene Focal segmental glomerulosclerosis type 4 susceptibility to Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Hepatology Nephrology Endocrinology Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test gene APOL1

Test Details: The APOL1 gene is associated with a condition called focal segmental glomerulosclerosis (FSGS) type 4. FSGS is a kidney disorder characterized by scarring of the glomeruli, which are the tiny blood vessels in the kidneys that filter waste from the blood. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the APOL1 gene. This test can identify specific variations or mutations in the gene that are associated with an increased risk of developing FSGS type 4. By detecting these genetic variations, NGS testing can help determine an individual’s susceptibility to FSGS type 4. This information can be useful in diagnosing the condition, predicting its progression, and guiding treatment decisions.

Test Name APOL1 Gene Focal segmental glomerulosclerosis type 4 susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hepatology Nephrology Endocrinology Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test gene APOL1
Test Details

The APOL1 gene is associated with a condition called focal segmental glomerulosclerosis (FSGS) type 4. FSGS is a kidney disorder characterized by scarring of the glomeruli, which are the tiny blood vessels in the kidneys that filter waste from the blood.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the APOL1 gene. This test can identify specific variations or mutations in the gene that are associated with an increased risk of developing FSGS type 4.

By detecting these genetic variations, NGS testing can help determine an individual’s susceptibility to FSGS type 4. This information can be useful in diagnosing the condition, predicting its progression, and guiding treatment decisions.